GILD

129.16

0.02% -0.02

시간 외 거래: 128.50 -0.66 -0.51%

길리어드 사이언스 (GILD)

개요 뉴스 가격 이력 옵션 체인 Financials GILD 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$129.18

열려 있는:

$130.09

하루 거래량:

13.41M

Relative Volume:

2.14

시가총액:

$160.36B

수익:

$29.79B

순이익/손실:

$9.22B

주가수익비율:

17.57

EPS:

7.3494

순현금흐름:

$10.23B

1주 성능:

-3.92%

1개월 성능:

-3.24%

6개월 성능:

+6.55%

1년 성능:

+16.93%

1일 변동 폭

$128.92

$131.66

1주일 범위

$127.07

$133.99

52주 변동 폭

$104.46

$157.29

길리어드 사이언스 Stock (GILD) Company Profile

명칭

Gilead Sciences Inc

부문

Healthcare (1102)

산업

Drug Manufacturers - General (20)

전화

(650) 574-3000

주소

333 LAKESIDE DR, FOSTER CITY, CA

직원

17,000

트위터

@GileadSciences

다음 수익 날짜

2026-05-07

최신 SEC 제출 서류

GILD's Discussions on Twitter

Compare GILD vs LLY, JNJ, ABBV, MRK, AZN

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
GILD Gilead Sciences Inc	129.16	160.39B	29.79B	9.22B	10.23B	7.3494
LLY Lilly Eli Co	1,131.42	1.00T	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	232.77	549.25B	96.36B	21.04B	17.80B	8.6488
ABBV Abbvie Inc	227.23	397.42B	62.82B	3.60B	19.98B	2.0274
MRK Merck Co Inc	120.79	297.02B	65.51B	8.93B	14.12B	3.5532
AZN Astrazeneca Plc	185.95	281.95B	60.48B	10.40B	8.05B	3.3297

길리어드 사이언스 Stock (GILD) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-03-10	개시	Jefferies	Buy
2026-02-20	개시	Barclays	Equal Weight
2026-02-11	재확인	Needham	Buy
2026-01-07	재개	UBS	Buy
2025-11-24	재개	Truist	Buy
2025-11-13	개시	Scotiabank	Sector Outperform
2025-08-19	업그레이드	Daiwa Securities	Neutral → Outperform
2025-08-08	업그레이드	Truist	Hold → Buy
2025-07-25	업그레이드	Needham	Hold → Buy
2025-04-22	재개	Cantor Fitzgerald	Overweight
2025-03-04	재확인	Oppenheimer	Outperform
2025-02-18	업그레이드	Deutsche Bank	Hold → Buy
2025-02-13	업그레이드	DZ Bank	Hold → Buy
2025-01-10	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	재개	BofA Securities	Buy
2024-11-15	개시	Wolfe Research	Outperform
2024-11-14	개시	Citigroup	Buy
2024-11-08	다운그레이드	Maxim Group	Buy → Hold
2024-10-21	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-17	개시	Bernstein	Outperform
2024-10-07	업그레이드	Wells Fargo	Equal Weight → Overweight
2024-07-08	업그레이드	Raymond James	Mkt Perform → Outperform
2024-05-01	재확인	Maxim Group	Buy
2024-04-24	업그레이드	HSBC Securities	Reduce → Hold
2024-02-22	다운그레이드	Truist	Buy → Hold
2023-11-09	개시	Deutsche Bank	Hold
2023-09-08	업그레이드	BofA Securities	Neutral → Buy
2023-09-06	개시	HSBC Securities	Reduce
2023-07-24	재확인	Barclays	Equal Weight
2023-05-16	업그레이드	BMO Capital Markets	Market Perform → Outperform
2023-04-28	재개	Piper Sandler	Overweight
2023-01-03	다운그레이드	RBC Capital Mkts	Outperform → Sector Perform
2022-12-13	재개	BofA Securities	Neutral
2022-12-09	다운그레이드	DZ Bank	Buy → Hold
2022-10-31	업그레이드	Barclays	Underweight → Equal Weight
2022-10-28	재확인	BMO Capital Markets	Market Perform
2022-10-28	재확인	Cowen	Outperform
2022-10-28	재확인	JP Morgan	Overweight
2022-10-28	재확인	Jefferies	Buy
2022-10-28	업그레이드	Piper Sandler	Neutral → Overweight
2022-10-28	재확인	RBC Capital Mkts	Outperform
2022-10-28	업그레이드	Truist	Hold → Buy
2022-10-28	재확인	Wells Fargo	Equal Weight
2022-10-04	업그레이드	JP Morgan	Neutral → Overweight
2022-07-13	개시	Cantor Fitzgerald	Neutral
2022-05-23	개시	SVB Leerink	Mkt Perform
2022-02-28	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2022-02-02	재확인	BMO Capital Markets	Outperform
2022-02-02	재확인	BofA Securities	Neutral
2022-02-02	재확인	RBC Capital Mkts	Outperform
2022-02-02	재확인	Truist	Hold
2022-02-02	재확인	Wells Fargo	Equal Weight
2022-01-28	업그레이드	Argus	Hold → Buy
2022-01-06	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-12-09	재개	Wells Fargo	Equal Weight
2021-12-06	개시	Goldman	Neutral
2021-11-19	업그레이드	BMO Capital Markets	Market Perform → Outperform
2021-11-19	재개	Piper Sandler	Neutral
2021-10-20	재개	Cowen	Outperform
2021-07-30	재확인	BMO Capital Markets	Market Perform
2021-07-30	재확인	RBC Capital Mkts	Outperform
2021-04-01	업그레이드	Bernstein	Mkt Perform → Outperform
2021-03-30	업그레이드	Redburn	Neutral → Buy
2021-01-19	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2021-01-04	업그레이드	Guggenheim	Neutral → Buy
2020-11-03	재개	Morgan Stanley	Equal-Weight
2020-10-28	개시	UBS	Neutral
2020-09-30	재개	Jefferies	Buy
2020-09-15	업그레이드	Maxim Group	Hold → Buy
2020-07-31	재확인	Credit Suisse	Neutral
2020-07-31	재확인	Morgan Stanley	Equal-Weight
2020-07-31	재확인	Piper Sandler	Overweight
2020-07-31	재확인	RBC Capital Mkts	Outperform
2020-07-31	재확인	SunTrust	Hold
2020-07-31	재확인	Wells Fargo	Equal Weight
2020-07-20	업그레이드	Credit Suisse	Underperform → Neutral
2020-06-03	업그레이드	SVB Leerink	Mkt Perform → Outperform
2020-05-26	업그레이드	SunTrust	Sell → Hold
2020-05-01	다운그레이드	JP Morgan	Overweight → Neutral
2020-05-01	다운그레이드	Raymond James	Outperform → Mkt Perform
2020-05-01	다운그레이드	SunTrust	Hold → Sell
2020-04-27	다운그레이드	UBS	Buy → Neutral
2020-04-20	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2020-04-20	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-04-17	다운그레이드	CFRA	Hold → Sell

모두보기

길리어드 사이언스 주식(GILD)의 최신 뉴스

04:11 AM

Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now? - Yahoo Finance

04:11 AM

06:47 AM

Gilead Sciences, Inc. $GILD Shares Purchased by ING Groep NV - MarketBeat

06:47 AM

06:36 AM

Los Angeles Capital Management LLC Sells 676,504 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

06:36 AM

04:40 AM

Capital World Investors Has $5.26 Billion Stake in Gilead Sciences, Inc. $GILD - MarketBeat

04:40 AM

Gilead Sciences, Inc. $GILD Shares Sold by Capital Research Global Investors - MarketBeat

04:40 AM

04:30 AM

Capital International Inc. CA Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

04:30 AM

DB&C Advisors LLC Invests $1.57 Million in Gilead Sciences, Inc. $GILD - MarketBeat

04:30 AM

12:39 PM

Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline - Yahoo Finance

12:39 PM

Jun 06, 2026

Westfield Capital Management Co. LP Takes $5.10 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 06, 2026

Vise Technologies Inc. Purchases 11,294 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 06, 2026

PBU The Pension Fund of Early Childhood & Youth Educators Purchases Shares of 95,333 Gilead Sciences, Inc. $GILD - MarketBeat

Jun 06, 2026

Gilead Sciences, Inc. $GILD Shares Sold by BI Asset Management Fondsmaeglerselskab A S - MarketBeat

Jun 06, 2026

111 Capital Sells 7,913 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 06, 2026

Jun 05, 2026

Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands - TradingView

Jun 05, 2026

Morgan Stanley Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $168 - Moomoo

Jun 05, 2026

Gilead Sciences, Lakefront Biotherapeutics Acquire Ouro Medicines - Contract Pharma

Jun 05, 2026

Harvest Fund Management Co. Ltd Acquires 13,385 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 05, 2026

Prudential PLC Trims Stake in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 05, 2026

GILD: Gilead Supports South Africa's Launch of Lenacapavir for H - GuruFocus

Jun 05, 2026

Gilead applauds efforts to launch lenacapavir for HIV prevention in South Africa - The Pharma Letter

Jun 05, 2026

Daiwa Securities Group Inc. Has $40.43 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 05, 2026

Cibc World Market Inc. Buys 97,779 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 05, 2026

Arrowpoint Investment Partners Singapore Pte. Ltd. Invests $2.38 Million in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 05, 2026

Key facts: Gilead completes $7.8B Arcellx buy; closes Ouro Medicines deal - TradingView

Jun 05, 2026

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa - Business Wire

Jun 05, 2026

Jun 04, 2026

Gilead, Merck, Eli Lilly lead $106B biopharma takeover wave in 2026 - MSN

Jun 04, 2026

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026 - Stocktwits

Jun 04, 2026

US FDA approves Gilead's drug for deadly liver infection - MSN

Jun 04, 2026

Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline - TradingView

Jun 04, 2026

Gilead Sciences (GILD) Has an HIV-and-Oncology Bridge That Makes the Base Business Harder to Ignore - AlphaStreet

Jun 04, 2026

Gilead and Lakefront complete Ouro Medicines acquisition - Investing.com

Jun 04, 2026

GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE - The Manila Times

Jun 04, 2026

Gilead’s Livdelzi approved by NICE for PBC - The Pharma Letter

Jun 04, 2026

TD Asset Management Inc Sells 67,251 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 04, 2026

Gilead eyes PBC expansion for Livdelzi on positive one-year data - Clinical Trials Arena

Jun 04, 2026

Jun 03, 2026

Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 03, 2026

GILD Reports Positive Results From Late-Stage Liver Disease Study - Yahoo Finance

Jun 03, 2026

With Cencora pact, Gilead looks to grow CAR-T treatment center network - Fierce Pharma

Jun 03, 2026

IDEAL Data Expands Gilead’s Livdelzi Evidence Into Lower-ALP PBC Population - Citeline News & Insights

Jun 03, 2026

Scotiabank Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $177 - Moomoo

Jun 03, 2026

Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Weakness - Yahoo Finance

Jun 03, 2026

Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance Singapore

Jun 03, 2026

Gilead Data On Livdelzi And Trodelvy Points To Broader Future Mix - simplywall.st

Jun 03, 2026

Marble Wealth LLC Acquires Shares of 9,588 Gilead Sciences, Inc. $GILD - MarketBeat

Jun 03, 2026

Natixis Advisors LLC Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat

Jun 03, 2026

CIBC Asset Management Inc Buys 128,992 Shares of Gilead Sciences, Inc. $GILD - MarketBeat

Jun 03, 2026

Gilead Sciences, Inc. Acquires Significant Stake in Assembly Biosciences Inc. - GuruFocus

Jun 03, 2026

Jun 02, 2026

Gilead Sciences, Inc. Acquires Significant Stake in Assembly Bio - GuruFocus

Jun 02, 2026

Insider Sell: Daniel O'Day Sells 15,000 Shares of Gilead Sciences Inc (GILD) - GuruFocus

Jun 02, 2026

How Investors Are Reacting To Gilead Sciences (GILD) Expanding Liver And Oncology Drug Footprint - Yahoo Finance

Jun 02, 2026

Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 15,000 Shares - MarketBeat

Jun 02, 2026